Does FOSTAMATINIB Cause Platelet count increased? 148 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Platelet count increased have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 2.3% of all adverse event reports for FOSTAMATINIB.
148
Reports of Platelet count increased with FOSTAMATINIB
2.3%
of all FOSTAMATINIB reports
3
Deaths
25
Hospitalizations
How Dangerous Is Platelet count increased From FOSTAMATINIB?
Of the 148 reports, 3 (2.0%) resulted in death, 25 (16.9%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Platelet count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 148 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
What Other Drugs Cause Platelet count increased?
RUXOLITINIB (1,667)
ELTROMBOPAG OLAMINE (980)
CLOZAPINE (745)
PREDNISONE (433)
ADALIMUMAB (404)
RITUXIMAB (400)
METHOTREXATE (356)
INFLIXIMAB (225)
OMALIZUMAB (223)
MONTELUKAST (211)
Which FOSTAMATINIB Alternatives Have Lower Platelet count increased Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM